Fluzone Quadrivalent Northern Hemisphere
Product Images NDC 49281-541

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fluzone Quadrivalent Northern Hemisphere (NDC 49281-541). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Pasteur Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.5 mL Syringe Package)

Label for Fluzone Quadrivalent Northern Hemisphere influenza vaccine, single-dose 0.5 mL, no preservative, 2022-2023 formula. The label indicates it is for intramuscular use only and is manufactured by Sanofi Pasteur Inc. It includes the NDC 49281-422-58 and spaces reserved for lot and expiry information.*

FDA Label Image

Principal Display Panel (0.25 mL Syringe Package)

Packaging label for Fluzone Quadrivalent Northern Hemisphere influenza vaccine by Sanofi Pasteur Inc. The 2022-2023 formula contains 10 single-dose 0.5 mL vials for intramuscular injection, recommended for ages 6 months and older. The label includes storage instructions and vaccine composition details. The NDC is 49281-422-10.*

FDA Label Image

Principal Display Panel (5 mL Vial Package)

Label of Fluzone Quadrivalent Northern Hemisphere 0.5 mL single-dose influenza vaccine by Sanofi Pasteur Inc. Key details include the NDC 49281-422-88, indication for intramuscular use only, no preservative formula, and reserved areas for lot number and expiry date. The label features barcode and QR code for identification.*

FDA Label Image

Fluzone 04

Packaging label for Fluzone Quadrivalent Northern Hemisphere, an influenza vaccine by Sanofi Pasteur Inc. The box contains 10 single-dose prefilled syringes of 0.5 mL each, for ages 6 months and older, for intramuscular injection only. It features information on storage, manufacturing, and the vaccine's four strains formulation for the 2022-2023 season.*

FDA Label Image

Fluzone 05

Packaging label for Fluzone Quadrivalent Influenza Vaccine by Sanofi Pasteur. It is formulated for 6 months of age and older and is intended for intramuscular injection. The box contains 10 single-dose prefilled syringes of 0.5 mL each, representing a 2022-2023 formula with 4 strains included. Storage and usage instructions are also present.*

FDA Label Image

Fluzone 06

Fluzone Quadrivalent Northern Hemisphere influenza vaccine 5 mL multi-dose vial label by Sanofi Pasteur Inc. This label indicates the vaccine is for intramuscular injection, contains preservative, and includes storage instructions to keep between 2° to 8°C. It also marks the vaccine as prescription-only and displays NDC 49281-637-78.*

FDA Label Image

Fluzone 07

Fluzone Quadrivalent Influenza Vaccine 5 mL multi-dose vial packaging label by Sanofi Pasteur Inc. for the 2022-2023 Northern Hemisphere formula. The label includes dosage instructions for intramuscular injection for ages 6 months and older, batch and expiration reserve area, storage instructions between 2° to 8°C, and information on vaccine strains and preservative content.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.